Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Tacrolimus vs Dexamethasone for Rapidly Progressing Vitiligo in Children
NCT06900777Recruiting
- Sponsor
- Xijing Hospital
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of tacrolimus + Wuzhi capsule in Vitiligo (2 arms), sponsored by Xijing Hospital. Primary endpoint: Percentage of Participants Achieving VASI 50 Response at 24 weeks. Started Apr 2025; status: recruiting.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT06900777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06900777.